Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: ACRIN 6695 Principal Investigator: Siegel, Cary
Title: Prognostic Perfusion CT in Gynecological Cancer: A Randomized Phase III Trial of Every-3-Weeks Paclitaxel versus Dose Dense Weekly Paclitaxel in Combination with Carboplatin with or without Concurrent and Consolidation Bevacizumab in the Treatment of Primary Stage I, II, III, or IV Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer (Ancillary to GOG 0262)
Phase: N/A Disease Site: Multiple Sites
Participating Site(s):
 
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

 
More Information:
Internal Protocol Documents (requires Siteman administrative database password)